The FDA has resurrected a morning-sickness treatment that went not-so-gently into the good night 30 years ago, on unfounded worries about birth defects. Diclegis, a tablet made by Canadian-based Duchesnay, is a new version of Bendectin, withdrawn in 1983 because its maker couldn't afford to fight lawsuits over its safety. Release | Report